129 results on '"Liu, Ting-Hui"'
Search Results
2. New-onset obstructive airway disease following COVID-19: a multicenter retrospective cohort study
3. Association between vitamin D deficiency and post-acute outcomes of SARS-CoV-2 infection
4. Clinical efficacy of enteral nutrition feeding modalities in critically ill patients: a systematic review and meta-analysis of randomized controlled trials
5. The effect of oral antiviral therapy for COVID-19 in managing non-hospitalized patients with lung cancer
6. Post-COVID-19 condition risk in patients with intellectual and developmental disabilities: a retrospective cohort study involving 36,308 patients
7. Comparison of post-acute sequelae following hospitalization for COVID-19 and influenza
8. Correction to: Efficacy and safety of adjunctive corticosteroids in the treatment of severe community‑acquired pneumonia: a systematic review and meta‑analysis of randomized controlled trials
9. Efficacy and safety of adjunctive corticosteroids in the treatment of severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials
10. Clinical efficacy of N-acetylcysteine for COVID-19: A systematic review and meta-analysis of randomized controlled trials
11. Efficacy of propofol-based anesthesia against risk of brain swelling during craniotomy: A meta-analysis of randomized controlled studies
12. Association between nirmatrelvir plus ritonavir and the outcomes of non-hospitalized obese patients with COVID-19
13. Omega-3 polyunsaturated fatty acids and the psychiatric post-acute sequelae of COVID-19: A one-year retrospective cohort analysis of 33,908 patients
14. Clinical efficacy of ertapenem vs. other carbapenems for the treatment of extended-spectrum-β-lactamase-producing Enterobacterales infection: A systematic review and meta-analysis
15. Malnutrition and the Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Multi-Institutional Population-Based Propensity Score-Matched Analysis.
16. Clinical effectiveness of nirmatrelvir plus ritonavir on the short‐ and long‐term outcome in high‐risk children with COVID‐19.
17. The clinical outcomes and effectiveness of antiviral agents among underweight patients with COVID-19.
18. Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases.
19. Real-world data analysis of post-COVID-19 condition risk in older patients.
20. Nutritional deficiency anemia and post‐acute sequelae in patients with severe acute respiratory syndrome coronavirus 2 infection: A six‐month retrospective cohort analysis of 30 892 patients.
21. The association between zinc deficiency, and clinical outcomes of COVID-19.
22. The effect of molnupiravir on post-acute outcome of COVID-19 survivors.
23. Clinical effectiveness of nirmatrelvir plus ritonavir in the treatment of COVID-19 in patients with cirrhosis.
24. Clinical Effectiveness of Nirmatrelvir plus Ritonavir in the Treatment of COVID-19 for Patients With Dementia
25. Risk of cytomegalovirus diseases among coronavirus disease survivors: A retrospective cohort study.
26. Effectiveness of oral antiviral agents on long‐term cardiovascular risk in nonhospitalized patients with COVID‐19: A multicenter matched cohort study.
27. The effect of nirmatrelvir‐ritonavir on the long‐term risk of neuropsychiatric sequelae following COVID‐19.
28. Diagnostic Efficacy of Carotid Ultrasound for Predicting the Risk of Perioperative Hypotension or Fluid Responsiveness: A Meta-Analysis.
29. The effect of nirmatrelvir plus ritonavir on the long-term risk of epilepsy and seizure following COVID-19: A retrospective cohort study including 91,528 patients
30. The risk of methicillin-resistant Staphylococcus aureus infection following COVID-19 and influenza: A retrospective cohort study from the TriNetX network
31. Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID‐19.
32. Clinical effectiveness of oral antiviral agents in older patients with COVID‐19 based on real‐world data.
33. Clinical efficacy of probiotics in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials.
34. Clinical effectiveness of nirmatrelvir plus ritonavir in patients with COVID‐19 and substance use disorders based on real‐world data.
35. Post-acute hospitalization and mortality of nirmatrelvir plus ritonavir for COVID-19 survivors.
36. Efficacy of nirmatrelvir and ritonavir for post‐acute COVID‐19 sequelae beyond 3 months of SARS‐CoV‐2 infection.
37. Long‐term risk of herpes zoster following COVID‐19: A retrospective cohort study of 2 442 686 patients.
38. Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID‐19: A systematic review and meta‐analysis of randomized control trials.
39. Characterization and Functional Analysis of OcomOBP7 in Ophraella communa Lesage.
40. Effectiveness of COVID-19 vaccination against multisystem inflammatory syndrome in children: A systematic review and meta-analysis
41. The association between corticosteroids and aspergillosis among COVID-19 patients.
42. Response to the letter to the editor on "Long‐term risk of herpes zoster following COVID‐19: A retrospective cohort study of 2 442 686 patients".
43. Response to the letter to the editor on "Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID‐19: A systematic review and meta‐analysis of randomized control trials".
44. The effect of zinc on the outcome of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials.
45. The association between zinc deficiency, and clinical outcomes of COVID-19
46. The preventive effect of inhaled antibiotic against ventilator-associated pneumonia: a systematic review and meta-analysis.
47. The effect of recombinant zoster vaccine on patients with chronic obstructive pulmonary diseases: A multi-institutional propensity score-matched cohort study.
48. Effectiveness of molnupiravir for treating COVID-19 in patients with psychiatric disorders.
49. Clinical effectiveness of nirmatrelvir plus ritonavir for patients with COVID-19 and preexisting psychiatric disorders.
50. Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre-existing chronic obstructive pulmonary diseases.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.